1.	Study To Evaluate Safety and Efficacy of P276-00 in Subjects With Refractory Multiple Myeloma Phase: Phase II, Phase I Type: Treatment Status: Closed Age: 18 to 80 Sponsor: Other Protocol IDs: P276-00/15/07, NCT00882063
2.	Safety and Efficacy Study of P276-00 in Combination With Gemcitabine in Patients With Advanced Pancreatic Cancer Phase: Phase II, Phase I Type: Treatment Status: Completed Age: 18 and over Sponsor: Other Protocol IDs: P276-00/28/08, NCT00898287
3.	Safety and Efficacy Study of P276-00 in Combination With Radiation in Subjects With Advanced Head and Neck Cancer Phase: Phase II, Phase I Type: Biomarker/Laboratory analysis, Treatment Status: Closed Age: 18 and over Sponsor: Other Protocol IDs: P276-00/31/08, NCT00899054
4.	A Phase II Clinical Trial to Study the Efficacy and Safety of a New Drug P276-00 in Treatment of Recurrent and/or Locally Advanced Head and Neck Cancer Phase: Phase II Type: Treatment Status: Closed Age: 18 and over Sponsor: Other Protocol IDs: P276-00/21/08, NCT00824343
5.	Efficacy Study Of P276-00 In Subjects Of Malignant Melanoma Positive For Cyclin D1 Expression Phase: Phase II Type: Treatment Status: Closed Age: 18 and over Sponsor: Other Protocol IDs: P276-00/27/08, NCT00835419
6.	Open Label Phase I Study of P276-00 in Patients With Advanced Refractory Neoplasms Phase: Phase I Type: Treatment Status: Completed Age: 19 and over Sponsor: Other Protocol IDs: P276-00/01/04, NCT00407498